EP 3600296 A1 20200205 - NOVEL COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING INSULIN RESISTANCE
Title (en)
NOVEL COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING INSULIN RESISTANCE
Title (de)
NEUARTIGE VERBINDUNGEN, ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON INSULINRESISTENZ
Title (fr)
NOUVEAUX COMPOSES, COMPOSITIONS ET METHODES POUR LE TRAITEMENT DE LA RESISTANCE A L'INSULINE
Publication
Application
Priority
- FR 1752287 A 20170320
- EP 2018056931 W 20180320
Abstract (en)
[origin: WO2018172306A1] The invention relates to a compound that inhibits interaction between a Grb14 protein and an insulin receptor, of formula (I) or of formula (II), the salts, solvates and/or diastereoisomers thereof, for use for therapeutic purposes, in particular for the treatment of insulin resistance, and pharmaceutical compositions containing such compounds.
IPC 8 full level
A61K 31/422 (2006.01); A61K 31/513 (2006.01); A61K 31/635 (2006.01); A61P 3/10 (2006.01); C07D 261/16 (2006.01)
CPC (source: EP US)
A61K 31/341 (2013.01 - US); A61K 31/42 (2013.01 - US); A61K 31/422 (2013.01 - EP US); A61K 31/513 (2013.01 - EP US); A61K 31/635 (2013.01 - EP); A61P 3/10 (2017.12 - EP US); C07D 239/545 (2013.01 - EP); C07D 413/12 (2013.01 - EP)
Citation (search report)
See references of WO 2018172306A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
FR 3063903 A1 20180921; FR 3063903 B1 20190412; EP 3600296 A1 20200205; US 11020378 B2 20210601; US 2020030297 A1 20200130; WO 2018172306 A1 20180927
DOCDB simple family (application)
FR 1752287 A 20170320; EP 18710891 A 20180320; EP 2018056931 W 20180320; US 201816496111 A 20180320